132 related articles for article (PubMed ID: 3085750)
41. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
[TBL] [Abstract][Full Text] [Related]
42. Metabolism of [1-14C]-arachidonic acid by cultured calf aortic endothelial cells: evidence for the presence of a lipoxygenase pathway.
Kühn H; Pönicke K; Halle W; Wiesner R; Schewe T; Förster W
Prostaglandins Leukot Med; 1985 Mar; 17(3):291-303. PubMed ID: 3921988
[TBL] [Abstract][Full Text] [Related]
43. Role of contaminating platelets in thromboxane synthesis in primary cultures of human umbilical vein endothelial cells.
Pfister SL; Hughes MJ; Rosolowsky M; Campbell WB
Prostaglandins Other Lipid Mediat; 2002 Sep; 70(1-2):39-49. PubMed ID: 12428677
[TBL] [Abstract][Full Text] [Related]
44. Eicosapentaenoic acid potentiates the production of prostacyclin-like material in the arachidonic acid perfused human umbilical vein.
Kristensen SD; Arnfred T; Dyerberg J
Thromb Res; 1984 Nov; 36(4):305-14. PubMed ID: 6098049
[TBL] [Abstract][Full Text] [Related]
45. Effects of dipyrone on prostaglandin production by human platelets and cultured bovine aortic endothelial cells.
Eldor A; Polliack G; Vlodavsky I; Levy M
Thromb Haemost; 1983 Apr; 49(2):132-7. PubMed ID: 6346571
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of thrombin- and ionomycin-stimulated prostacyclin and platelet-activating factor production in cultured endothelial cells by a tumor-promoting phorbol ester.
Zavoico GB; Hrbolich JK; Gimbrone MA; Schafer AI
J Cell Physiol; 1990 Jun; 143(3):596-605. PubMed ID: 2113537
[TBL] [Abstract][Full Text] [Related]
47. Phorbol esters and oleoyl acetoyl glycerol enhance release of arachidonic acid in platelets stimulated by Ca2+ ionophore A23187.
Halenda SP; Zavoico GB; Feinstein MB
J Biol Chem; 1985 Oct; 260(23):12484-91. PubMed ID: 3930496
[TBL] [Abstract][Full Text] [Related]
48. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
[TBL] [Abstract][Full Text] [Related]
49. The differences in 12-hydroxyeicosatetraenoic acid and thromboxane B2 release from guinea pig platelets.
Mike I; Ichikawa Y; Shimizu T; Honda ZI; Seyama Y; Ishii A
Prostaglandins; 1991 Nov; 42(5):431-40. PubMed ID: 1763200
[TBL] [Abstract][Full Text] [Related]
50. Impact of insulin or tolbutamide treatment on 14C-arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas, and platelets of streptozotocin-induced diabetic rats.
Valentovic MA; Lubawy WC
Diabetes; 1983 Sep; 32(9):846-51. PubMed ID: 6354792
[TBL] [Abstract][Full Text] [Related]
51. IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis.
Zavoico GB; Ewenstein BM; Schafer AI; Pober JS
J Immunol; 1989 Jun; 142(11):3993-9. PubMed ID: 2497185
[TBL] [Abstract][Full Text] [Related]
52. Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart.
Schrör K; Köhler P; Müller M; Peskar BA; Rösen P
Am J Physiol; 1981 Jul; 241(1):H18-25. PubMed ID: 6264810
[TBL] [Abstract][Full Text] [Related]
53. Arachidonic acid availability and prostacyclin production by cultured human endothelial cells.
Spector AA; Kaduce TL; Hoak JC; Czervionke RL
Arteriosclerosis; 1983; 3(4):323-31. PubMed ID: 6411051
[TBL] [Abstract][Full Text] [Related]
54. Production of eicosanoids by deendothelialized rabbit aorta: interaction between platelets and vascular wall in the synthesis of prostacyclin.
Papp AC; Crowe L; Pettigrew LC; Wu KK
Thromb Res; 1986 May; 42(4):549-56. PubMed ID: 3520943
[TBL] [Abstract][Full Text] [Related]
55. Increased platelet activity after termination of prostacyclin infusion into man.
Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
[TBL] [Abstract][Full Text] [Related]
56. Human platelet secreted proteins and prostacyclin production by bovine aortic endothelial cells.
Poggi A; Niewiarowski S; Stewart GJ; Sobel E; Smith JB
Proc Soc Exp Biol Med; 1983 Apr; 172(4):543-50. PubMed ID: 6221344
[TBL] [Abstract][Full Text] [Related]
57. Elucidation of a role of plasma albumin during collagen-induced aggregation of bovine platelets.
Sekiya F; Takagi J; Saito Y
Thromb Res; 1989 Nov; 56(3):407-15. PubMed ID: 2515611
[TBL] [Abstract][Full Text] [Related]
58. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue.
Matzky R; Darius H; Schrör K
Arzneimittelforschung; 1982; 32(10):1315-8. PubMed ID: 6817760
[TBL] [Abstract][Full Text] [Related]
59. Comparison of prostanoid synthesis in cultured human vascular endothelial cells derived from omentum and umbilical vein.
Stansby G; Shukla N; Hamilton G; Jeremy J
Eur J Vasc Surg; 1991 Oct; 5(5):501-6. PubMed ID: 1959679
[TBL] [Abstract][Full Text] [Related]
60. Optimization of an assay for studying the effects of agents on cyclooxygenase and lipoxygenase metabolism of arachidonic acid in washed human platelets.
Dragan YP; Ellis EF
Prostaglandins Leukot Essent Fatty Acids; 1990 Feb; 39(2):105-9. PubMed ID: 2111551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]